alexa
Reach Us +44-1904-929220
Breast Cancer Proliferative Activity: Is It The Source Of Free Serum DNA? | 8947
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Breast cancer proliferative activity: Is it the source of free serum DNA?

4th International Conference on Biomarkers & Clinical Research

Taha Ismail Hewala and Nadia Ahmad Abd El-Moneim

AcceptedAbstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.019

Abstract
Aim: To study the relationship between serum DNA and breast cancer proliferative activity, and then compare the diagnostic and prognostic value of serum DNA, TPS and CEA. Subjects and Methods: A total of 100 breast cancer patients before surgery and 50 normal healthy controls were analyzed for serum DNA, TPS and CEA. Results: Serum DNA levels were non-significantly correlated with serum TPS levels. Serum DNA, TPS and CEA levels were significantly higher in patients than controls. Using ROC curve analysis, serum TPS and DNA had the highest AUC compared to serum CEA. Neither serum TPS, DNA nor CEA correlated with breast cancer clinicopathological data. Only serum CEA was significantly correlated with patients' disease-free survival, but serum DNA and TPS did not show this correlation. Conclusion: Neither Breast cancer mass nor proliferative activity is the source of free serum DNA. Serum TPS is superior to DNA and CEA as a diagnostic marker for breast cancer. Only preoperative serum CEA has a prognostic role in predicting relapse of breast cancer patients, but not serum TPS and DNA.
Biography
Taha Ismail Hewala has completed his Ph.D. at the age of 31 years from Alexandria University and Assistant Professor in the field of cancer diagnosis and therapy at the age of 36 from Alexandria University. He is the Head of Radiation Sciences Department, Medical Research Institute, Alexandria University. He has published 8 papers in different international and local journals.
Relevant Topics
Top